[Terlipressin as a new therapeutic agent in septic shock].
The hemodynamic support of sepsis is now formulated trying to insert terlipressin as salvage drug in catecholamine resistant shock, justifying a broad critical analysis. The analysis included hemodynamic therapies with defined specific goals and new recommendations for fluid resuscitation, vasopressor therapy, and inotropic therapy of septic in adult and pediatric patients. Terlipressin appears as a new but controversial alternative for vasopressor therapy in sepsis.